Qianfeng Zhuang

Dr. Qianfeng Zhuang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2018 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
RWRongzu Wu
Rongzu Wu
TWTingchun Wu
Tingchun Wu
KWKai Wang
Kai Wang
SLshicheng luo
shicheng luo
ZCZhen Chen
Zhen Chen
XXXianlin Xu
Xianlin Xu
The prognostic significance of galectin-1 (Gal-1) expression in cancerous patients has been assessed for several years while the results remain controversial. Thus, we performed the first comprehensive meta-analysis to evaluate the prognostic value of Gal-1 expression in cancerous patients. We searched Pubmed, Embase and Web of Science to recruit studies on the prognostic impact of Gal-1 expression in cancerous patients. Eighteen studies containing 2674 patients were involved in this meta-analysis until March 30, 2018. Pooled hazard ratios (HRs) with 95% confidence interval (95% CI) were calculated to estimate the effect using random-effects model. The pooled results revealed that high Gal-1 expression in cancer tissue associated with a poor OS (HR = 1.79, 95% CI 1.54–2.08, P < 0.001). In the subgroup of tumor type, it’s observed that high Gal-1 expression was significant correlated with poor OS in digestive cancers without heterogeneity (HR = 1.94, 95% CI 1.64–2.30, P < 0.001; fixed-effects model; I2 = 20.1%, P = 0.276). Our present meta-analysis indicates that high Gal-1 expression might be a predictive factor of poor prognosis in cancers, particularly in digestive cancers.

11 January 2021 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
HJHao Jiang
Hao Jiang
JTJing-Yuan Tang
Jing-Yuan Tang
DXDong Xue
Dong Xue
YCYi-Meng Chen
Yi-Meng Chen
TWTing-Chun Wu
Ting-Chun Wu
XHXiao-Zhou He
Xiao-Zhou He
Background: Renal cell carcinoma (RCC) is a clinically common tumor in the urinary system, showing an upward trend of both incidence and mortality. Apolipoprotein C1 (APOC1) has been identified as a vital regulator in tumor progression. This study aims to uncover the biological function of APOC1 in RCC process and the underlying mechanism. Methods: Differential levels of APOC1 in RCC samples and normal tissues in a downloaded TCGA profile and clinical samples collected in our center were detected by quantitative reverse transcription PCR (qRT-PCR). The prognostic value of APOC1 in RCC was assessed by depicting Kaplan–Meier survival curves. After intervening APOC1 level by transfection of sh-APOC1 or oe-APOC1, changes in phenotypes of RCC cells were examined through CCK-8, colony formation, Transwell assay and flow cytometry. Subsequently, protein levels of EMT-related genes influenced by APOC1 were determined by Western blot. The involvement of the Wnt3a signaling in APOC1-regulated malignant process of RCC was then examined through a series of rescue experiments. Finally, a RCC xenograft model was generated in nude mice, aiming to further clarify the in vivo function of APOC1 in RCC process. Results: APOC1 was upregulated in RCC samples. Notably, its level was correlated to overall survival of RCC patients, displaying a certain prognostic value. APOC1 was able to stimulate proliferative, migratory and invasive abilities in RCC cells. The Wnt3a signaling was identified to be involved in APOC1-mediated RCC process. Notably, Wnt3a was able to reverse the regulatory effects of APOC1 on RCC cell phenotypes. In vivo knockdown of APOC1 in xenografted nude mice slowed down the growth of RCC. Conclusions: APOC1 stimulates the malignant process of RCC via targeting the Wnt3a signaling.

2 February 2025 in Sexual Medicine
Verified
Journal Article
Open access
BZBo Zhang
Bo Zhang
YGYi Gu
Yi Gu
YCYiming Chen
Yiming Chen
WXWei Xia
Wei Xia
NSNaiyuan Shao
Naiyuan Shao
XFXingliang Feng
Xingliang Feng
Background: The C-reactive protein-triglyceride glucose index (CTI) is a recently introduced index designed to simultaneously assess inflammation (via CRP) and insulin resistance (via the triglyceride-glucose index, TyG), both of which are recognized risk factors for declining testosterone levels in men. Aim: This study investigates the association between CTI and low testosterone levels in American adult men, aiming to evaluate CTI as a predictor of low testosterone level. Methods: Data from the 2015–2016 NHANES were used in this cross-sectional study, including men aged 20 and older. Multivariate linear and logistic regression models were employed to analyze the relationship between CTI, total testosterone levels, and the risk of low testosterone level. Receiver operating characteristic (ROC) curves were generated to assess the predictive performance of CTI for low testosterone level. Outcomes: The primary outcome was testosterone levels, with low testosterone level defined as a serum testosterone level below 300 ng/dL in adult men. Results: Among 878 participants, 189 had low testosterone level. The mean CTI was significantly higher in the low testosterone level group (9.39 ± 0.09) compared to the non- low testosterone level group (8.62 ± 0.05; P < .0001). After adjusting for covariates, higher CTI was significantly associated with lower total testosterone levels (β = –44.6, 95% CI: –66.34, –22.87, P < .001) and increased low testosterone level risk (OR = 1.84, 95% CI: 1.31, 2.57, P = .002). ROC analysis showed that CTI (AUC = 0.7357, 95% CI: 0.6975, 0.7739) outperformed TyG and VAI in predicting low testosterone level, highlighting its potential clinical value in assessing low testosterone status. Clinical Implications: Timely monitoring of testosterone levels in individuals with elevated CTI is clinically significant. Additionally, for those with TD, regular assessment of CTI may help in preventing future cardiovascular complications. Strengths and limitations: This study is the first to explore the relationship between CTI and low testosterone using a large sample from the NHANES database. However, due to the cross-sectional design, causal inference regarding CTI and low testosterone level cannot be drawn. Conclusions: CTI appears to be a more effective predictor of low testosterone level than TyG, CRP, or VAI, suggesting its usefulness as a simple, low-cost indicator for early TD risk assessment. Further research is needed to verify its clinical applicability across diverse populations.

14 August 2025 in BMC Endocrine Disorders
Verified
Journal Article
Open access
YMYangyang Mei
Yangyang Mei
BZBo Zhang
Bo Zhang
YCYiming Chen
Yiming Chen
RXRenfang Xu
Renfang Xu
DXdong xue
dong xue
XFXingliang Feng
Xingliang Feng
Testosterone is essential for male health, and its decline is closely associated with inflammation and lipid metabolism. The ratio of circulatory immune cells to high-density lipoprotein cholesterol (HDL-C) can comprehensively reflect these underlying pathophysiological mechanisms, including the neutrophil-to-HDL-C (NHR), platelet-to-HDL-C (PHR), monocyte-to-HDL-C (MHR), and lymphocyte-to-HDL-C (LHR). This study is the first to comprehensively assess the relationship between these ratios and male testosterone levels, as well as their ability to predict testosterone deficiency (TD). The study data were derived from the NHANES 2011–2016 cycles, including adult males who with data on the aforementioned indicators. Multivariable linear regression and logistic regression analyses were performed to assess the impact of these ratios on total testosterone levels and the risk of TD, respectively. Smoothed curve fitting was used to determine potential nonlinear relationships. Additionally, ROC analysis was conducted to compare the predictive ability of NHR, PHR, MHR, and LHR for TD. Finally, subgroup analysis was performed to confirm the stability of the results. A total of 6,079 participants were included in the study, with 1,680 participants having TD. In the fully adjusted models, log-transformed NHR, PHR, MHR, and LHR were all linearly negatively associated with total testosterone levels and linearly positively associated with the risk of TD. Specifically, for NHR, the corresponding beta and odds ratio (OR) were (β = -66.58, 95% CI: -78.08, -55.08, P < 0.0001) and (OR = 2.21, 95% CI: 1.76, 2.77, P < 0.0001), respectively. Similarly, for PHR, the OR for the risk of TD was 2.24 (95% CI: 1.64, 3.05, P < 0.0001), for MHR, the OR was 1.82 (95% CI: 1.42, 2.32, P < 0.0001), and for LHR, the OR was 2.11 (95% CI: 1.63, 2.74, P < 0.0001), indicating significant positive associations with TD risk. Additionally, ROC analysis indicated that NHR had the best predictive ability for TD among the ratios, with the highest AUC of 0.640 (95% CI: 0.625–0.655) and consistent results across subgroups. Our results suggest that log-transformed NHR, PHR, MHR, and LHR are positively associated with the risk of TD, with NHR being an effective predictor of TD. These findings highlight the potential of NHR to serve as an accessible supplementary biomarker for identifying men who may be at higher risk of TD, supporting early risk stratification and guiding further evaluation where appropriate. However, further prospective cohort studies are essential to validate our findings.

1 August 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
YSYifan Shao
Yifan Shao
QZQianfeng Zhuang
Qianfeng Zhuang

1 October 2025 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
YMYangyang Mei
Yangyang Mei
YCYiming Chen
Yiming Chen
WXWei Xia
Wei Xia
RXRenfang Xu
Renfang Xu
DXdong xue
dong xue
XFXingliang Feng
Xingliang Feng
Background: Beyond traditional risk factors, public health has increasingly focused on the impact of social determinants of health (SDoHs) on disease risk. However, no studies have systematically evaluated the effects of both individual and cumulative SDoHs on the risk of erectile dysfunction (ED), representing a critical gap that our study aims to address. Methods: Data were collected from a representative sample of adult men participating in the U.S. National Health and Nutrition Examination Survey (NHANES) from 2001 to 2004. Self-reported SDoHs were categorized based on Healthy People 2030 criteria, with a cumulative score of favorable SDoHs created for analysis. ED was assessed using a validated single-item measure. Multivariable regression models were used to examine the effects of individual and cumulative SDoHs on ED risk. Subgroup and sensitivity analyses were conducted to enhance the robustness of the results. Results: A total of 3,489 eligible participants were included, with 1,001 diagnosed with ED. Unfavorable SDoHs showed significant associations with increased ED risk: being unemployed [odds ratio (OR): 1.97, 95% confidence interval (CI): 1.40, 2.77], family income-to-poverty ratio <300% (OR: 1.65, 95% CI: 1.32, 2.06, P<0.001), marginal-to-very-low food security (OR: 1.50, 95% CI: 1.02, 2.20, P=0.04), high school education or lower (OR: 1.41, 95% CI: 1.09, 1.81, P=0.01), and non-homeownership (OR: 1.23, 95% CI: 1.01, 1.53, P=0.04). A strong inverse relationship was observed between the cumulative count of favorable SDoHs and ED risk (OR: 0.83, 95% CI: 0.75, 0.93, P=0.002). When treated as categorical variables, lower-middle [3–4] and low levels [0–2] of SDoHs were associated with higher ED risk (ORs: 1.76 and 2.62, P<0.05). Additionally, sensitivity analysis showed that the low-level group (0–2 SDoHs) had a significantly higher risk of severe ED compared to the high-level group (OR =3.78, 95% CI: 1.26, 11.34, P=0.02). Conclusions: The findings suggest that unfavorable SDoHs, particularly when accumulated, are associated with increased risk of ED among U.S. men. Addressing unfavorable SDoHs should be a public health priority, not only to improve male sexual health, but also to promote health equity and overall population well-being. Large-scale population cohort studies are underway to provide higher-level evidence supporting our conclusions.